Pharma sector outlook: ICRA pegs 7-9% revenue growth for FY26, US headwinds cloud prospects
India’s pharmaceutical sector is projected to post healthy revenue growth of 7-9 per cent in FY26, aided by robust demand in the domestic and European markets, even as momentum in the United States is expected to cool, according to rating agency ICRA.The domestic market is expected to expand by 8-10 per cent and Europe by…